Abstract
Ghrelin, a 28-amino acid peptide predominantly produced by the stomach, displays strong GH-releasing activity mediated by the GH secretagogue (GHS)-receptor (GHS-R) type 1a at the hypothalamus-pituitary level. Ghrelin and synthetic GHS also possess other GH-independent peripheral endocrine and non-endocrine activities via the activation of peripheral GHS-R subtypes. In rats in vivo non-acylated ghrelin has been reported devoid of any endocrine activity; however, in vitro, it has been shown as effective as ghrelin in exerting anti-proliferative activity on tumor cell lines. The aim of the present study was to clarify whether non-acylated human ghrelin shares some of the endocrine activities of its acylated form in humans. To this goal, the effects of acylated or non-acylated ghrelin (1.0 μg/kg iv at 0 min) on GH, PRL, ACTH, F, insulin and glucose levels were studied in two different testing sessions in 7 normal young volunteers (age [mean±SE]: 24.3±1.7 yr; BMI: 21.5±0.9 kg/m2). The effects of placebo administration were also studied. The administration of acylated ghrelin induced prompt and marked increase in circulating GH levels (AUC: 5452.4±904.9 μg*min/l; p<0.01 vs placebo) and significant increase in PRL (1273.5±199.7 μg*min/l; p<0.01 vs placebo), ACTH (4482.7±954.4 pg*min/ml; p<0.01 vs placebo) and F levels (15985.0±1141.9 μg*min/l; p<0.01 vs placebo). Its administration was also followed by decrease in insulin levels (1448.67±137.9 mU*min/l; p<0.05 vs placebo) that was coupled with an increase in plasma glucose levels (10974.2±852.5 mg*min/dl; p<0.05 vs placebo). The administration of non-acylated ghrelin and that of placebo did not induce any change in the hormonal parameters or in glucose levels. In conclusion, this study shows that in humans nonacylated ghrelin does not possess the pituitaric and pancreatic endocrine activities of human ghrelin octanoylated in Serine 3.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656–660.
Kojima M., Hosoda H., Matsuo H., Kangawa K. Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol. Metabol. 2001, 12: 118–122.
Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat. Rev. Neurosci. 2001, 2: 551–560.
Takaya K., Ariyasu H., Kanamoto N. et al. Ghrelin strongly stimulates growth hormone release in humans. J. Clin. Endocrinol. Metab. 2000, 85: 4908–4011.
Ghigo E., Arvat E., Giordano R. et al. Biologic activities of growth hormone secretagogues in humans. Endocrine 2001, 14: 87–93.
Smith R.G., van der Ploeg L.H., Howard A.D. et al. Peptidomimetic regulation of growth hormone secretion. Endocr. Rev. 1997, 18: 621–645.
Papotti M., Ghè C., Cassoni P. et al. Growth hormone secretagogue binding sites in peripheral human tissues. J. Clin. Endocrinol. Metab. 2000, 85: 3803–3807.
Volante M., Allia E., Gugliotta P. et al. Expression of ghrelin and of GHS receptor by pancreatic islet cells and related endocrine tumors. J. Clin. Endocrinol. Metab. 2002, 87: 1300–1308.
Date Y., Nakazato M., Hashiguchi S. et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002, 51: 124–129.
Arvat E., Maccario M., Di Vito L. et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J. Clin. Endocrinol. Metab. 2001, 86: 1169–1174.
Horvath T.L., Diano S., Sotonyi P., Heiman M.L., Tschop M. Ghrelin and the regulation of energy homeostasis: A hypothalamic perspective. Endocrinology 2001, 142: 4163–4169.
Zhang W., Chen M., Chen X., Segura B.J., Mulholland M.W. Inhibition of pancreatic protein secretion by ghrelin in the rat. J. Physiol. 2001, 537: 231–236.
Broglio F., Arvat E., Benso A. et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J. Clin. Endocrinol. Metab. 2001, 86: 5083–5086.
Nagaya N., Kojima M., Uematsu M. et al. Hemodynamic and hormonal effects of human ghrelin in healthy volunteers. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2001, 280: R1483–R1487.
Nagaya N., Uematsu M., Kojima M. et al. Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001, 104: 1430–1435.
Cassoni P., Papotti M., Catapano F. et al. Specific binding sites for synthetic growth hormone secretagogues in non-tumoral and neoplastic human thyroid tissue. J. Endocrinol. 2000, 165: 139–146.
Cassoni P., Papotti M., Ghè C. et al. Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J. Clin. Endocrinol. Metab. 2001, 86: 1738–1745.
Ghè C., Cassoni P., Catalano F. et al. The Antiproliferative Effect of Synthetic Peptidyl Growth Hormone Secretagogues (GHS) in CALU-1 Lung Carcinoma Cells. Endocrinology 2002, 143: 484–491.
Date Y., Kojima M., Hosoda H. et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000, 141: 4255–4261.
Hewson A.K., Dickson S.L. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats. J. Neuroendocrinol. 2000, 12: 1047–1049.
Bednarek M.A., Feighner S.D., Pong S.S. et al. Structurefunction studies on the new growth hormone-releasing peptide, ghrelin: minimal sequence of ghrelin necessary for activation of growth hormone secretagogue receptor 1a. J. Med. Chem. 2000, 43: 4370–4376.
Matsumoto M., Hosoda H., Kitajima Y. et al. Structure-activity relationship of ghrelin: pharmacological study of Ghrelin peptides. Biochem. Biophys. Res. Commun. 2001, 287: 142–146.
Arvat E., Di Vito L., Broglio F. et al. Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J. Endocrinol. Invest. 2000, 23: 493–495.
Date Y., Nakazato M., Murakami N., Kojima M., Kangawa K., Matsukura S. Ghrelin acts in the central nervous system to stimulate gastric acid secretion. Biochem. Biophys. Res. Commun. 2001, 280: 904–907.
Muccioli G., Papotti M., Locatelli V. et al. Binding of 125I-labeled ghrelin to membranes from human hypothalamus and pituitary gland. J. Endocrinol. Invest. 2001, 24: RC7–RC9.
Muccioli G., Tschop M., Papotti M., Deghenghi R., Heiman M., Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur. J. Pharmacol. 2002, 440: 235–254.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Broglio, F., Benso, A., Gottero, C. et al. Non-acylated ghrelin does not possess the pituitaric and pancreatic endocrine activity of acylated ghrelin in humans. J Endocrinol Invest 26, 192–196 (2003). https://doi.org/10.1007/BF03345156
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345156